MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

about

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

Item

http://www.wikidata.org/entity/Q55319096

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@en

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@nl

type

Item

label

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@en

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@nl

prefLabel

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@en

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@nl

P1476

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

@en

P2093

Cristian Coarfa

http://www.w3.org/2001/XMLSchema#string

Eveline Barberi

http://www.w3.org/2001/XMLSchema#string

Giovanni Perini

http://www.w3.org/2001/XMLSchema#string

Jason M Shohet

http://www.w3.org/2001/XMLSchema#string

Kimal Rajapakshe

http://www.w3.org/2001/XMLSchema#string

Ronald Bernardi

http://www.w3.org/2001/XMLSchema#string

Saurabh Agarwal

http://www.w3.org/2001/XMLSchema#string

Zaowen Chen

http://www.w3.org/2001/XMLSchema#string

P2860

p53 is regulated by the lysine demethylase LSD1

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

MYC, Metabolism, and Cancer

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription

Super-enhancers in the control of cell identity and disease

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

Role of p53 serine 46 in p53 target gene regulation.

A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.

CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.

P304

20323-20338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24859

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan Koster

Giorgio Milazzo

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755654

http://www.w3.org/2001/XMLSchema#string

P932

5945521

http://www.w3.org/2001/XMLSchema#string